Opportunities and barriers in omics-based biomarker discovery for steatotic liver diseases
Publikation: Bidrag til tidsskrift › Review › Forskning › fagfællebedømt
Originalsprog | Engelsk |
---|---|
Tidsskrift | Journal of Hepatology |
ISSN | 0168-8278 |
DOI | |
Status | E-pub ahead of print - 2024 |
Bibliografisk note
Funding Information:
This project has received funding from the GALAXY project from the European Union's Horizon 2020 research and innovation programme under grant agreement number 668031; and from Challenge Grant \u201CMicrobLiver\u201D grant number NNF15OC0016692 from the Novo Nordisk Foundation. LVE is funded by the Fonds Wetenschappelijk Onderzoek (FWO) Vlaanderen (grant number: 1S25720N). MT is funded by a grant from the Novo Nordisk Foundation (NNF20OC0059393). KS is supported by the Novo Nordisk Foundation Excellence Emerging Investigator Grant \u2013 Endocrinology and Metabolism 2022 (grant no. NNF 0074491). LTD is funded by grants from the Novo Nordisk Foundation (NNF22OC0078203 and NNF23OC0081177). JT was supported by the German Research Foundation (DFG) project ID 403224013 \u2013 SFB 1382 (A09), by the German Federal Ministry of Education and Research (BMBF) for the DEEP-HCC project and by the Hessian Ministry of Higher Education, Research and the Arts (HMWK) for the ENABLE and ACLF-I cluster projects. The MICROB-PREDICT (project ID 825694), DECISION (project ID 847949), GALAXY (project ID 668031), LIVERHOPE (project ID 731875) and IHMCSA (project ID 964590) projects have received funding from the European Union's Horizon 2020 research and innovation programme. LJJ is funded by the Novo Nordisk Foundation (NNF14CC0001). The manuscript reflects only the authors\u2019 views, and the European Commission is not responsible for any use that may be made of the information it contains. The funders had no influence on literature used, preparation of the manuscript or where to publish.
ID: 392456005